Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学In Situ Vaccination and Intratumoral Therapy

Brendan Curti

MD

🏢Providence Cancer Institute🌐USA

Investigator, Earle A. Chiles Research Institute

40
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Brendan Curti has developed intratumoral cytokine delivery approaches including IL-2 formulations designed to concentrate immune activation within tumors while minimizing systemic toxicity. His clinical trials of intratumoral immune agonists in melanoma and renal cell carcinoma have demonstrated favorable safety-efficacy profiles. He has advanced the concept of localized immune activation as a complement to systemic immunotherapy.

Share:

🧪Research Fields 研究领域

Intratumoral IL-2 therapy
In situ immune activation
Renal cell carcinoma IO
Intratumoral cytokine delivery
Adoptive T cell therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Brendan Curti 的研究动态

Follow Brendan Curti's research updates

留下邮箱,当我们发布与 Brendan Curti(Providence Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment